Junfeng Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA modifications and cancer 10
- Receptor Mechanisms and Signaling 8
- RNA Research and Splicing 7
- Advanced biosensing and bioanalysis techniques 6
- Epidemiology 28
- Liver Disease Diagnosis and Treatment 15
- Co-authors
- Yusen Zhou (11 shared papers)Xue Chen (4 shared papers)Shihui Sun (7 shared papers)Yan Guo (6 shared papers)Guangyu Zhao (6 shared papers)Lanying Du (6 shared papers)Shibo Jiang (5 shared papers)Yuting Jiang (3 shared papers)
- Journals
- Frontiers in Pharmacology (4 papers)Scientific Reports (4 papers)International Journal of Molecular Sciences (3 papers)Medicine (3 papers)Cardiovascular Diabetology (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Junfeng Li
202 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 162
- Cancer Research 385
- Infectious Diseases 386
- Molecular Biology 1.3k
- Immunology 335
- Hepatology 101
Countries citing papers authored by Junfeng Li
This map shows the geographic impact of Junfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Li more than expected).
Fields of papers citing papers by Junfeng Li
This network shows the impact of papers produced by Junfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Li. The network helps show where Junfeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 156 | |
| 2 | 2020 | 81 | |
| 3 | 2015 | 68 | |
| 4 | 2020 | 65 | |
| 5 | 2015 | 63 | |
| 6 | 2019 | 62 | |
| 7 | 2020 | 59 | |
| 8 | 2020 | 57 | |
| 9 | 2014 | 56 | |
| 10 | 2020 | 52 | |
| 11 | 2017 | 49 | |
| 12 | 2016 | 47 | |
| 13 | 2001 | 43 | |
| 14 | 2016 | 42 | |
| 15 | 2004 | 41 | |
| 16 | 2009 | 41 | |
| 17 | 2018 | 40 | |
| 18 | 2017 | 40 | |
| 19 | 2018 | 39 | |
| 20 | 2017 | 38 |
About Junfeng Li
Junfeng Li is a scholar working on Molecular Biology, Epidemiology, Surgery, Cancer Research and Immunology, having authored 216 papers that have together received 3.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (10 papers), Pancreatic function and diabetes (8 papers), MicroRNA in disease regulation (8 papers), Receptor Mechanisms and Signaling (8 papers), RNA Research and Splicing (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Cancer Research (385 citations), Infectious Diseases (386 citations), Molecular Biology (1.3k citations), Immunology (335 citations) and Hepatology (101 citations). Junfeng Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yusen Zhou, Xue Chen, Shihui Sun, Yan Guo, Guangyu Zhao, Lanying Du, Shibo Jiang, Yuting Jiang, Pan Xue and Yuehong Chen. Their work appears in journals such as Frontiers in Pharmacology, Scientific Reports, International Journal of Molecular Sciences, Medicine and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.